Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent Supports Inaugural Singapore-South Korea Symposium on Glycomics

Published: Saturday, February 15, 2014
Last Updated: Saturday, February 15, 2014
Bookmark and Share
Event follows collaboration to develop tools for analysis of biologics, vaccines.

Agilent Technologies Inc. has announced support for the inaugural Singapore-South Korea Symposium on Glycomics, where scientists and researchers from both nations will work toward developing biomarkers for diseases, biopharmaceuticals and therapeutic antibody products through glycomics, the study of complex sugars. The symposium will be held Feb. 12-13 in Singapore.

"This joint symposium marks increasing collaboration with our partners from South Korea in the field of glycomics, with the aim to establish Singapore and South Korea as Asian leaders in glycomics research," said professor Lam Kong Peng, executive director of the Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*STAR). "Singapore has developed biomedical sciences as a key pillar of our economy-these collaborations will further boost Singapore's reputation as a world-class destination for biologics manufacturing and R&D."

The symposium is organized by BTI; the Korea Basic Science Institute (KBSI), one of South Korea's foremost research institutions; and Chungnam National University's Graduate School of Analytical Science and Technology (GRAST), one of South Korea's top universities and a highly regarded research leader in the field of glycomics. KBSI will lead a delegation of 35 scientists and postgraduate students from South Korea to Singapore for the symposium.

"We believe science is integral to our everyday lives, helping us to stay safe and improve our well-being," said Dr. Kwanghwa Chung, president of KBSI. "KBSI is moving forward to be an open and global science research institution, and we are committed to ongoing research and collaboration with notable organizations in Singapore, such as the Bioprocessing Technology Institute."

"GRAST leads the way in developing the biosimilars industry in South Korea," said professor Hee-Sun Chung, dean of GRAST. "We are the only graduate school in South Korea that leverages the synergistic efforts of education and research. We welcome opportunities for our researchers and students to share our work in the field of glycomics and contribute to the discovery of new cures, more effective drugs and vaccines to treat serious medical conditions."

"Agilent has long been the champion of innovation, driving developments and collaborations among members of scientific community," said Dr. Rudolf Grimm, Agilent's director of science and technology and manager of collaborations in the Asia-Pacific region. "We are committed to helping top scientists who work in the important field of glycomics and biopharmaceuticals in Singapore and South Korea to pave the way for discoveries and developments that will help people live better and longer, safely."

In Singapore, BTI is Agilent's reference site in Southeast Asia for the use of the unique mAb-Glyco NanoChip Technology. BTI is home to a number of sophisticated bio-analytical instruments including the Agilent 6550 iFunnel Ultra High Accurate Mass Q-TOF LC/MS which contains the HPLC-Chip breakthrough technology for glycoprotein analysis.

The symposium follows a number of research collaboration initiatives by Agilent in the field of glycomics, which include, among others:

• 2011 - Collaboration with Chungnam National University to develop new applications, methods, technologies and software tools in the field of glycomics.
• 2013 - Establishment of the Asia Glycomics Education, located in GRAST, to support collaborative university/industry education and cross-training. The university will develop and administer training programs for various methods of glycan analysis, which will be made available without charge to scientists and researchers endorsed by Agilent in South Korea and the South Asia-Pacific region.
• 2013 - Memorandum of understanding signed between Agilent, the Glyco-MEV laboratory at the University of Rouen, France, and the Bioprocessing Technology Institute. The three parties plan to develop tools that will analyze biologics and vaccines to ensure they are safe and effective.
• Collaborations with U.C. Davis, Boston University School of Medicine, Macau University of Science and Technology and Macquarie University in Sydney.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent, Eurofins Genomics Collaborate
Agilent plans to offer custom components and an assembled plasmid service for Agilent’s SureVector next-generation cloning kits through a collaboration with Eurofins.
Monday, March 14, 2016
Best Practices for Breast Cancer Diagnosis
Agilent has published “Breast Cancer Diagnosis: Past, Present and Future,” a white paper on the use of immunohistochemistry in diagnosing and treating breast cancer.
Monday, March 14, 2016
Agilent Invests $80M in Lasergen
Company has announced that it has invested $80 million in Lasergen, with innovative next-generation sequencing technology for clinical applications.
Friday, March 11, 2016
Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics
Company has announced a program that gives biologists conducting functional genomics research early access to a potential new resource.
Saturday, February 13, 2016
Agilent Technologies and 10x Genomics Announce Collaboration
Company has announced collaboration to develop a premium exome that provides a streamlined workflow for 10x Genomics'Chromium platform.
Friday, February 12, 2016
Agilent Wins Award for Innovation in LC
Dual-needle technology enhances speed, flexibility.
Thursday, January 28, 2016
Agilent Extends Agreement with PerkinElmer on Bioanalyzer Chips
PerkinElmer supplies chips for Agilent's popular 2100 Bioanalyzer system.
Thursday, January 21, 2016
Agilent Signs Agreement with Thermo Fisher Scientific
Agreement to exchange instrument controls to improve the productivity and user experience.
Thursday, November 12, 2015
Agilent Completes Acquisition of Seahorse Bioscience
Agilent has completed the acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics.
Tuesday, November 03, 2015
Agilent Recognizes Australian Genome Research Facility as Certified Service Provider
Nonprofit organization offers scientists access to leading-edge technologies.
Saturday, October 31, 2015
Agilent Announces Opening of Life Science Research Center
Facility designed to advance multi-omics research.
Thursday, September 24, 2015
Agilent to Acquire Seahorse Bioscience
Acquisition complements Agilent’s market-leading separations and mass spectrometry solutions, expands pharma offerings.
Thursday, September 10, 2015
Agilent, Singapore Institute Collaborate
Agilent Technologies and Singapore's Bioprocessing Technology Institute today announced a collaboration to develop new analytical approaches to specific protein-linked sugar compounds.
Wednesday, July 15, 2015
Agilent Collaborate with A*STAR’s Bioprocessing Technology Institute
Collaboration addresses a critical need in the biopharmaceutical industry.
Tuesday, July 14, 2015
Agilent Technologies and Waters Corporation Formalize Instrument Control Exchange
Agilent Technologies Inc. and Waters Corp have announced a formal agreement to exchange instrument controls to improve the productivity of customers who own software and instruments from both companies.
Wednesday, July 01, 2015
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!